These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7642210)

  • 1. Importance of the third thrombospondin repeat of C6 for terminal complement complex assembly.
    Würzner R; Mewar D; Fernie BA; Hobart MJ; Lachmann PJ
    Immunology; 1995 Jun; 85(2):214-9. PubMed ID: 7642210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
    Kusunoki Y
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies.
    Würzner R; Schulze M; Happe L; Franzke A; Bieber FA; Oppermann M; Götze O
    Complement Inflamm; 1991; 8(5-6):328-40. PubMed ID: 1724954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human complement component C6: an amino acid substitution (Glu/Ala) within the second thrombospondin repeat differentiates between the two common allotypes C6 A and C6 B.
    Dewald G; Nöthen MM; Cichon S
    Biochem Biophys Res Commun; 1993 Jul; 194(1):458-64. PubMed ID: 8101442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6.
    Würzner R; Hobart MJ; Fernie BA; Mewar D; Potter PC; Orren A; Lachmann PJ
    J Clin Invest; 1995 Apr; 95(4):1877-83. PubMed ID: 7535801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.
    Fischetti F; Durigutto P; Macor P; Marzari R; Carretta R; Tedesco F
    Arthritis Rheum; 2007 Apr; 56(4):1187-97. PubMed ID: 17393439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.
    Würzner R; Xu H; Franzke A; Schulze M; Peters JH; Götze O
    Immunology; 1991 Sep; 74(1):132-8. PubMed ID: 1718850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis.
    Tramontini N; Huber C; Liu-Bryan R; Terkeltaub RA; Kilgore KS
    Arthritis Rheum; 2004 Aug; 50(8):2633-9. PubMed ID: 15334478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neutrophil adhesion and the membrane attack complex of complement synergistically prolongs cardiac xenograft survival.
    Davis EA; Lam TT; Qian Z; Ibrahim S; Baldwin WM; Sanfilippo FP
    J Heart Lung Transplant; 1995; 14(5):973-80. PubMed ID: 8800736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
    Høgåsen AK; Würzner R; Abrahamsen TG; Dierich MP
    J Immunol; 1995 May; 154(9):4734-40. PubMed ID: 7722325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte complement: a possible role for C5 in lymphocyte stimulation.
    Sundsmo JS
    J Immunol; 1983 Aug; 131(2):886-91. PubMed ID: 6223096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex.
    Mollnes TE; Lea T; Frøland SS; Harboe M
    Scand J Immunol; 1985 Aug; 22(2):197-202. PubMed ID: 2412280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes.
    Lin K; Zhang L; Kong M; Yang M; Chen Y; Poptic E; Hoffner M; Xu J; Tam C; Lin F
    Blood Adv; 2020 May; 4(9):2049-2057. PubMed ID: 32396613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.
    Hugo F; Berstecher C; Krämer S; Fassbender W; Bhakdi S
    Clin Exp Immunol; 1989 Jul; 77(1):112-6. PubMed ID: 2766574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
    Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion.
    Kilgore KS; Park JL; Tanhehco EJ; Booth EA; Marks RM; Lucchesi BR
    J Mol Cell Cardiol; 1998 Jan; 30(1):75-85. PubMed ID: 9500866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement membrane attack complex formation and infectivity of Trichinella spiralis and T. nativa in rats.
    Näreaho A; Saari S; Meri S; Sukura A
    Vet Parasitol; 2009 Feb; 159(3-4):263-7. PubMed ID: 19038499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalysis of disulfide isomerization in thrombospondin 1 by protein disulfide isomerase.
    Hotchkiss KA; Chesterman CN; Hogg PJ
    Biochemistry; 1996 Jul; 35(30):9761-7. PubMed ID: 8703948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.